CompletedPhase 1NCT01005004
Study of Human Central Nervous System (CNS) Stem Cells Transplantation in Pelizaeus-Merzbacher Disease (PMD) Subjects
Studying Pelizaeus-Merzbacher disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- StemCells, Inc.
- Principal Investigator
- Stephen Huhn, MDStemCells, Inc.
- Intervention
- HuCNS-SC cells(biological)
- Enrollment
- 4 enrolled
- Eligibility
- 5 years · MALE
- Timeline
- 2009 – 2012
Study locations (1)
- University of California, San Francisco, San Francisco, California, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01005004 on ClinicalTrials.govOther trials for Pelizaeus-Merzbacher disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT06150716Orbit Study: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Intrathecally Administered ION356 in Participants With Pelizaeus Merzbacher Disease (PMD)Ionis Pharmaceuticals, Inc.
- RECRUITINGNCT05659901Rocket Study: A Study to Characterize Biomarkers and Disease Progression in Participants With Pelizaeus-Merzbacher DiseaseIonis Pharmaceuticals, Inc.